1024P Initial Clinical Results of BT-001, an Oncolytic Virus Expressing an Anti-Ctla4 Mab, Administered As Single Agent and in Combination with Pembrolizumab in Patients with Advanced Solid Tumors
Annals of Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined